| Derek J Schmidt, MD | |
|
401 Phalen Blvd, Saint Paul, MN 55130-5302 | |
| (651) 254-8550 | |
| (651) 254-8558 |
| Full Name | Derek J Schmidt |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 25 Years |
| Location | 401 Phalen Blvd, Saint Paul, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801856588 | NPI | - | NPPES |
| 996420700 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 47090 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hudson Hospital | Hudson, WI | Hospital |
| Regions Hospital | Saint paul, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthpartners Medical Group | 1759293954 | 1430 |
| Healthpartners Medical Group | 1759293954 | 1430 |
News Archive
Children in early grades may like a subject in which they don?t feel very competent, or they may feel competent in a subject in spite of poor grades.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
A new paper published in the preprint server medRxiv* in August 2020 reports the design and preliminary findings of an ongoing study on pregnant mothers and their children born during the pandemic.
UnitedHealth Group and its family of companies are authorizing plan participants who are affected by the floods in Georgia and enrolled in its fully insured health plans and pharmacy benefit management (PBM) services to obtain early refills of their prescription medications. In addition, a free help line is available for people who are coping with the emotional consequences of the floods.
CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.
› Verified 3 days ago
| Entity Name | Group Health Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
Children in early grades may like a subject in which they don?t feel very competent, or they may feel competent in a subject in spite of poor grades.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
A new paper published in the preprint server medRxiv* in August 2020 reports the design and preliminary findings of an ongoing study on pregnant mothers and their children born during the pandemic.
UnitedHealth Group and its family of companies are authorizing plan participants who are affected by the floods in Georgia and enrolled in its fully insured health plans and pharmacy benefit management (PBM) services to obtain early refills of their prescription medications. In addition, a free help line is available for people who are coping with the emotional consequences of the floods.
CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derek J Schmidt, MD 8170 33rd Ave, Mail Stop 21110q, Bloomington, MN 55425-4516 Ph: (952) 883-5340 | Derek J Schmidt, MD 401 Phalen Blvd, Saint Paul, MN 55130-5302 Ph: (651) 254-8550 |
News Archive
Children in early grades may like a subject in which they don?t feel very competent, or they may feel competent in a subject in spite of poor grades.
Regado Biosciences, Inc., today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.
A new paper published in the preprint server medRxiv* in August 2020 reports the design and preliminary findings of an ongoing study on pregnant mothers and their children born during the pandemic.
UnitedHealth Group and its family of companies are authorizing plan participants who are affected by the floods in Georgia and enrolled in its fully insured health plans and pharmacy benefit management (PBM) services to obtain early refills of their prescription medications. In addition, a free help line is available for people who are coping with the emotional consequences of the floods.
CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.
› Verified 3 days ago
Dr. Daniel Scott Schneider, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1021 Bandana Blvd West, Saint Paul, MN 55108 Phone: 651-241-9700 | |
Phi Chau Doan, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1021 Bandana Blvd E Ste 100, Saint Paul, MN 55108 Phone: 651-241-9700 | |
Dr. Emily Becker, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 401 Phalen Blvd, Saint Paul, MN 55130 Phone: 651-254-8550 Fax: 651-254-8558 | |
Brianne Barnett Roby, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 347 Smith Ave N, Pediatric Ent And Facial Plastic Surgery, Suite 600, Saint Paul, MN 55102 Phone: 612-874-1292 | |
Christopher Wright Hilton, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 401 Phalen Blvd, Mail Stop: 11503j, Saint Paul, MN 55130 Phone: 651-254-8550 Fax: 651-254-8558 | |
Michelle Christine Naylor, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 347 Smith Ave N, Suite 602, Saint Paul, MN 55102 Phone: 651-227-0821 Fax: 651-297-6597 | |
Sarah E Shefelbine, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1020 Bandana Blvd W, Saint Paul, MN 55108 Phone: 651-641-7000 |